Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma

M. Schiller, A. Tsianakas, W. Sterry, R. Dummer, A. Hinke, D. Nashan, R. Stadler

Open source

DOI
10.1111/jdv.14366
Published
2017-07-20
Container
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdv.14366,
  title = {Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma},
  author = {M. Schiller and A. Tsianakas and W. Sterry and R. Dummer and A. Hinke and D. Nashan and R. Stadler},
  year = {2017},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  doi = {10.1111/jdv.14366},
  url = {https://doi.org/10.1111/jdv.14366}
}

RIS

TY  - JOUR
TI  - Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma
AU  - M. Schiller
AU  - A. Tsianakas
AU  - W. Sterry
AU  - R. Dummer
AU  - A. Hinke
AU  - D. Nashan
AU  - R. Stadler
PY  - 2017
JO  - Journal of the European Academy of Dermatology and Venereology
DO  - 10.1111/jdv.14366
UR  - https://doi.org/10.1111/jdv.14366
ER  - 

APA

Schiller, M., Tsianakas, A., Sterry, W., Dummer, R., Hinke, A., Nashan, D., & Stadler, R. (2017). Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.14366

Source records